US Stock MarketDetailed Quotes

ROIV Roivant Sciences

Watchlist
  • 10.740
  • +0.360+3.47%
Close Feb 28 16:00 ET
  • 10.740
  • 0.0000.00%
Post 16:43 ET
7.66BMarket Cap-56.53P/E (TTM)

About Roivant Sciences Company

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

Company Profile

SymbolROIV
Company NameRoivant Sciences
Listing DateDec 14, 2020
Founded2021
CEOMr. Matthew Gline
MarketNASDAQ
Employees908
Fiscal Year Ends03-31
Address50 Broadway,7th Floor
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeSW1H 0BD
Phone44-207-400-3347
Websitehttp://www.roivant.com

Company Executives

  • Name
  • Position
  • Salary
  • Matthew Gline
  • Chief Executive Officer and Director
  • 738.19K
  • Dr. Mayukh Sukhatme
  • President, Chief Investment Officer and Director
  • 574.56K
  • Dr. Eric Venker, M.D.,Pharm.D.
  • President and Chief Operating Officer
  • --
  • Jennifer Humes
  • Principal Accounting Officer; Chief Accounting Officer of RSI
  • --
  • Richard Pulik
  • Chief Financial Officer
  • 5.15M
  • Ilan Oren
  • Chairman of the Board
  • 488.49K
  • James C. Momtazee
  • Independent Director
  • 459.24K
  • Daniel Gold
  • Independent Director
  • 449.24K
  • Keith Manchester, M.D.
  • Independent Director
  • 442.59K
  • Dr. Meghan M. Fitzgerald, Ph.
  • Independent Director
  • 941.68K
  • Melissa B. Epperly
  • Independent Director
  • 444.24K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!